Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan C McCreary

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
AJNR. American Journal of Neuroradiology|February 12, 2026
Understanding the Therapeutic Impact of Disease-Modifying Therapies or No Treatment on Enlarging T1-Weighted Hypointense Lesions and Total T1-Weighted Hypointense Lesion Volume in MSDarin T Okuda, Tom G Punnen, Tatum M Moog, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 2, 2020
Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology PopulationPeter V Sguigna, Morgan C McCreary, Darrel L Conger, et al.
Neuro-Ophthalmology (Aeolus Press)|December 22, 2022
Application of the International Interocular Difference Thresholds into Practice: Localising the Patient ExperiencePeter V Sguigna, Lauren M Tardo, Kyle M Blackburn, et al.
Frontiers in Neurology|November 28, 2022
APDM gait and balance measures fail to predict symptom progression rate in Parkinson's diseaseD Campbell Dewey, Shilpa Chitnis, Morgan C McCreary, et al.
AJNR. American Journal of Neuroradiology|April 24, 2026
Longitudinal Cortical Surface Signatures Distinguish Neuromyelitis Optica Spectrum Disorder from Multiple SclerosisDarin T Okuda, Thomas A Stanley, Morgan C McCreary, et al.
Multiple Sclerosis and Related Disorders|November 16, 2025
Why the disease modifying therapy transition? Investigating the reasons and clinical consequences in multiple sclerosisDarin T Okuda, Tom G Punnen, Tatum M Moog, et al.
Neurology and Therapy|June 27, 2026
Utility of Multi-Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from PseudoexacerbationDarin T Okuda, Tatum M Moog, Morgan C McCreary, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 20, 2023
Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective studyPeter V Sguigna, Sabeen Toranian, Lauren M Tardo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 3, 2026
Clinical and radiological outcomes of directed treatment transitions from Gilenya<sup>®</sup> to generic fingolimodMahi A Patel, Tom G Punnen, Kevin S Shan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
AJNR. American Journal of Neuroradiology|February 12, 2026
Understanding the Therapeutic Impact of Disease-Modifying Therapies or No Treatment on Enlarging T1-Weighted Hypointense Lesions and Total T1-Weighted Hypointense Lesion Volume in MSDarin T Okuda, Tom G Punnen, Tatum M Moog, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 2, 2020
Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology PopulationPeter V Sguigna, Morgan C McCreary, Darrel L Conger, et al.
Neuro-Ophthalmology (Aeolus Press)|December 22, 2022
Application of the International Interocular Difference Thresholds into Practice: Localising the Patient ExperiencePeter V Sguigna, Lauren M Tardo, Kyle M Blackburn, et al.
Frontiers in Neurology|November 28, 2022
APDM gait and balance measures fail to predict symptom progression rate in Parkinson's diseaseD Campbell Dewey, Shilpa Chitnis, Morgan C McCreary, et al.
AJNR. American Journal of Neuroradiology|April 24, 2026
Longitudinal Cortical Surface Signatures Distinguish Neuromyelitis Optica Spectrum Disorder from Multiple SclerosisDarin T Okuda, Thomas A Stanley, Morgan C McCreary, et al.
Multiple Sclerosis and Related Disorders|November 16, 2025
Why the disease modifying therapy transition? Investigating the reasons and clinical consequences in multiple sclerosisDarin T Okuda, Tom G Punnen, Tatum M Moog, et al.
Neurology and Therapy|June 27, 2026
Utility of Multi-Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from PseudoexacerbationDarin T Okuda, Tatum M Moog, Morgan C McCreary, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 20, 2023
Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective studyPeter V Sguigna, Sabeen Toranian, Lauren M Tardo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 3, 2026
Clinical and radiological outcomes of directed treatment transitions from Gilenya<sup>®</sup> to generic fingolimodMahi A Patel, Tom G Punnen, Kevin S Shan, et al.
Pageof 1